- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Complaint alleged a NICE COPD treatment algorithm on a Trelegy promotional webpage indirectly promoted Anoro/Relvar without prescribing information.…
A US-only Apretude in-app advert was briefly visible to UK users after geo-restrictions failed. Panel initially found a…
Allergan challenged Xeomin promotional claims in a BMJ ad, leavepiece and conference stand panels. The Panel ruled some…
A Times diabetes supplement funded and editorially controlled by Novo Nordisk included an interview describing liraglutide trial benefits.…
Boehringer’s medical information letter and a “scientific” congress stand were found to promote Pradaxa (dabigatran) for unlicensed indications…
A Sanofi-Aventis rep asked a hospital consultant to countersign a shotgun licence renewal form during/around product discussion in…
Anonymous employee alleged “huge bonuses” and incentives for field staff. Panel initially found breach of 15.7 and 9.1…
BMJ analysis suggested Menarini had unreported EUCTR trial results (69.6% disclosed). PMCPA found most trials had no UK…
A GP alleged a renal referral education meeting was disguised promotion of Trajenta (linagliptin). The Panel found insufficient…
Pfizer Ireland exhibited at an ISU meeting in Belfast held at a 5-star hotel with golf and a…
One real case. One key lesson. Every week — free.